TY - JOUR T1 - Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study JF - Clin Infect Dis Y1 - 2008 A1 - Tedaldi, E. A1 - Peters, L. A1 - Neuhaus, J. A1 - et, al ED - Puoti, M. ED - J K Rockstroh ED - Klein, M.B. ED - Dore, G.J. ED - Mocroft, A. ED - Soriano, V. ED - Clotet, B. ED - Lundgren, J.D. KW - administration & dosage KW - Adult KW - Anti-Retroviral Agents KW - Antibodies KW - Antigens KW - blood KW - complications KW - drug therapy KW - epidemiology KW - Female KW - hepatitis KW - Hepatitis B KW - Hepatitis B Surface Antigens KW - Hepatitis B Virus KW - Hepatitis C KW - Hepatitis C Antibodies KW - HIV Infections KW - Humans KW - Incidence KW - Interruption KW - Male KW - Medicine KW - methods KW - Middle Aged KW - Mortality KW - Patients KW - Philadelphia KW - Research KW - Research Support KW - Risk KW - Risk Factors KW - therapeutic use KW - therapy VL - 47 SP - 1468-1475 IS - 11 ER -